Catalytic activities, protein- and mRNA-expression of cytochrome P450 isoenzymes in intestinal cell lines

Xenobiotica

Volumn 28, Issue 5, 1998, Pages 429-441

  Lampen, A ^a   Bader, A ^b   Bestmann, T ^b   Winkler, M ^b   Witte, L ^c   Borlak, J T ^b,d  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

^d Solvay Pharmaceuticals GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

12 HYDROXYMETHYL 7 METHYLBENZ[A]ANTHRACENE; 13 O DEMETHYLTACROLIMUS; 7 HYDROXYMETHYL 12 METHYLBENZ[A]ANTHRACENE; 7,12 BIS(HYDROXYMETHYL)BENZ[A]ANTHRACENE; 7,12 DIMETHYLBENZ[A]ANTHRACENE; BISDEMETHYLHYDROXYTACROLIMUS; CARCINOGEN; CYTOCHROME P450 ISOENZYME; DEMETHYLDIHYDROXYTACROLIMUS; DIHYDRODIHYDROXY 7,12 DIMETHYLBENZ[A]ANTHRACENE; DRUG METABOLITE; IMMUNOSUPPRESSIVE AGENT; MESSENGER RNA; TACROLIMUS; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CATALYSIS; CELL LINE; CONTROLLED STUDY; FETUS; HUMAN; HUMAN CELL; INTESTINE CELL; NONHUMAN; PROTEIN EXPRESSION; RAT; XENOBIOTIC METABOLISM;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; BIOTRANSFORMATION; CATALYSIS; CELL LINE; CELLS, CULTURED; COLONIC NEOPLASMS; CYTOCHROME P-450 ENZYME SYSTEM; DUODENUM; FETUS; HUMANS; ILEUM; INTESTINE, SMALL; ISOENZYMES; KINETICS; MICROSOMES; MICROSOMES, LIVER; PROTEIN BIOSYNTHESIS; RATS; RNA, MESSENGER; SUBSTRATE SPECIFICITY; TACROLIMUS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0031810016     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/004982598239362     Document Type: Article

References (54)

1. ARTURSSON, P., 1990, Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2-cells. Journal of Pharmaceutical Science, 79, 476-482.
2. ARTURSSON, P. and KARLSSON, J., 1991, Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochemical and Biophysical Research Communications, 175, 880-805.
3. AUDERBERG, E. K., NYSTROM, C. and ARTURSSON, P., 1992, Epithelial transport of drugs in cell culture. VII : Effects of pharmaceutical surfactant excipients and bile acids on transepithelial permeability in monolayers of human epithelial (CaCO-2) cells. Journal of Pharmaceutical Science, 81, 879-887.
4. BARGETZI, M. J., AOYAMA, J., GONZALEZ, F. J. and MEYER, U. A., 1989, Lidocaine metabolism in human liver microsomes by cytochrome P450 III A4. Clinical Pharmacology, 46, 521-527.
5. BEAUNE, P. H., UMBENAUER, D. R., BORK, R. W., LLOYD, S. and GUENGERICH, F. P., 1986, Isolation and sequence determination of a cDNA clone related to human cytochrome P450 nifedipine oxidase. Proceedings of the National Academy of Sciences, USA 83, 8064-8068.
6. BOULENC, X., BOURRIE, M., FABRE, I., ROQUE, C., JOYEUX, H., BERGER, Y., and FABRE, G., 1992, Regulation of cytochrome P450IA1 gene expression in a human intestinal cell line, Caco-2. Journal of Pharmacology and Experimental Therapeutics, 263, 1471-1478.
7. BOYLAND, E. and SIMS, P., 1965, Metabolism of polycyclic compounds, the metabolism of 7,12-dimethylbenz[a]anthracene by rat-liver homogenates. Biochemical Journal, 95, 780-787.
8. CHOMZYNSKI, P. and SACCHI, N., 1987, Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anals of Biochemistry, 162, 156-159.
9. CHRISTIANS, U., BRAUN, F., KOSIAN, N., SCHMIDT, M., SCHIEBEL, H. M., ERNST, L., KRUSE, C., WINKLER, M., HOLZE, I., LINCK, A. et al., 1991a, High performance liquid chromatography/mass spectrometry of FK 505 and its metabolites in blood, bile, and urine of liver grafted patients. Transplant Proceedings, 23, 2741-2742.
10. CHRISTIANS, U., KRUSE, C., KOWNATZKI, R., SCHIEBEL, H. M., SCHWINZER, R., SATTLER, M., SCHOTTMANN, R., LINCK, A., ALMEIDA, V. M., BRAUN, F. et al., 1991b, Measurement of FK 506 by HPLC and isolation and characterization of its metabolites. Transplant Proceedings, 23, 940-941.
11. COMBALBERT, J., FABRE, G., FABRE, I., DALET, J., DERANCOURT, J. P., CANO, P., and MAUREL, P., 1989, Metabolism of cyclosporin A. IV. Purification and identification of the rifampicin-inducible human liver cytochrome P450 (Cytochrom A Oxidase) as a product of P-450 IIIA. Drug Metabolism and Disposition, 17, 197-207.
12. CROSS, H. S., HUBER, C. and PETERLIK, M., 1991, Antiproliferative effect of 1,25-dihydroxyvitamin D3 and its analogs on human colon adenocarcinoma cells (CaCo-2): influence of extracellular calcium. Biochemical Biophysical Research Communications, 179, 57-62.
13. ESTABROOK, R. W. and WERRINGLOER, J., 1978, The measurement of difference spectra: application to the cytochromes of microsomes. Methods in Enzymology, 52, 212-220.
14. GAREN, A. and LEVINTHAL, C., 1960, A fine structure genetic and chemical study of the enzyme alkaline phosphatase of E. coli. I. Purification and characterization of alkaline phosphatase. Biochmica et Biophysica Acta, 38, 470-483.
15. GENTIL, A., LASNE, C. and CHOUROULINKOV, I., 1974, Metabolism of 7,12-dimethylbenz[a]anthracene by hamster live homogenates. Xenobiotica, 4, 537-548.
16. GONSCHIOR, A. K., CHRISTIANS, U., BRAUN, F., WINKLER, M., LINCK, A., BAUMANN, J. and SEWING, K. F., 1994, Measurement of blood concentrations of FK 506 (tacrolimus) and its metabolites in seven liver graft patients after the first dose h.p.l.c. and microparticle enzyme immunoassay (MEIA). British Journal of Clinical Pharmacology, 38, 567-671.
17. GONZALEZ, F. J., 1992, Human cytochromes P450: problems and prospects. Trends in Pharmacology, 13, 346-352.
18. GUENGERICH, F. P., 1982, Microsomal enzymes involved in toxicology - analysis and separation. In Principles and Methods of Toxicology, edited by A. W. Hayes (New York: Raven), pp. 603-634.
19. GUENGERICH, F. P., MARTIN, M. V., BEAUNE, P. H., KREMERS, P., WOLFF, T. and WAXMAN, D. J., 1986, Characterization of rat and human liver microsomal cytochrome P450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism. Journal of Biological Chemistry, 261, 5051-5060.
20. HAYES, A. W., 1982, Microsomal enzymes involved in toxicology - analysis and separation. In Principles and Methods of Toxicology, edited by F. P. Guengerich (NY, USA: Raven Press), pp. 603-634.
21. HIDALGO, I. J. and BORCHARDT, R. T., 1990, Transport of bile acids in a human intestinal epithelial cell line, Caco-2. Biochimica et Biophysica Acta, 1035, 97-103.
22. HIDALGO, I. J., RAUB, T. J. and BORCHARDT, R. T., 1989, Characterization of the human colon carcinoma cell line (caco-2) as a model system for intestinal epithelial permeability. Gastroenterology, 96, 736-49.
23. HILGERS, A. R., CONRADI, R. A. and BURTON, P. S., 1990, Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa. Pharmacology Research, 7, 902-910.
24. KAMINSIKI, L. S. and FASCON, M. J., 1992, Small intestinal cytochromes P450. Critical Reviews in Toxicology, 21, 407-422.
25. PINKUS, L. M., 1981, Separation and use of enterocyte. In Methods in Enzymology, vol. 77, edited by W. B. Jakoby (New York: Academic), 154-162.
26. KAMINSIKI, L. S. and FASCON, M. J., 1992, Small intestinal cytochromes P45. Critical Reviews, Toxicology, 21, 407-422.
27. KARLSSON, J., KUO, S. M., ZIEMNIAK, J. and ARTURSSON, P., 1993, Transport of celiprolol across human intestinal epithelial (Caco-2) cells: mediation of secretion by multiple transporters including P-glycoprotein. British Journal of Pharmacology, 110, 1009-1016.
28. KOLARS, J. C., SCHMIEDLIN, R. P., SCHUETZ, J. D., FANG, C. and WATKINS, P. B., 1992b, Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes. Journal of Clinical Investigation, 90, 1871-8.
29. KOLARS, J., STETSON, P., RUSH, B., RUWART, M., SCHMIEDLIN-REN, P., DUELL, E., VOORHEES, J. and WATKINS, P., 1992a, Cyclosporine metabolism by P4503A in rat enterocytes, another determinant of oral bioavailability? Transplantation, 53, 596-602.
30. KRONBACH, T., FISCHER, V. and MEYER, U. A., 1988, Cyclosporine metabolism in human liver: identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs. Clinical Pharmacology and Therapeutics, 43, 630-635.
31. LAEMMLI, U. K., 1970, Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680-685.
32. LAMPEN, A., CHRISTIANS, U., GONSCHIOR, A. K., BADER, A., HACKBARTH, I., ENGLEHARDT, W. and SEWING, K.-F., 1996a, Metabolism of the macrolide immunosuppressant tacrolimus in the pig gut mucosa in the ussing chamber. British Journal of Pharmacology, 117, 1730-1734.
33. LAMPEN, A., CHRISTIANS, U., GUENGERICH, F. P., WATKINS, P. B., KOLARS, J. C., BADER, A., GONSCHIOR, A. K., DRALLE, H., HACKBARTH, I. and SEWING, K. F., 1996b, Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability. Drug Metabolism Disposition, 23, 1315-1324.
34. LENZEN, S., DRINKGERN, J. and TIEDGE, M., 1996, Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radicals in Biology and Medicine, 20, 463-466.
35. MCKAY, J., MURRAY, G., WEAVER, R., EWEN, S., MELVIN, W. and BURKE, M., 1993, Xenobiotic metabolising enzyme expression in colonic neoplasia. Gut, 34, 1234-1239.
36. MCKINNON, R., BURGESS, W., HALL, P. D. L. M., ROBERTS-THOMSON, S., GONZALES, F. and MCMANUS, M., 1995, Characterisation of CYP3A subfamily expression in human gastrointestian tissues. Gut, 36, 259-267.
37. MCNICHOLAS, C. M., TURNBERG, L. A. and BROW, C. D., 1990, Sequential isolation of structural intact villus tip and crypt units from rat duodenum. Journal of Physiology, 429, 99.
38. NORDSTRÖM, C., DAHLQVIST, A. and JOSEFFSON, L., 1967, Quantitative determination of enzymes in different part of the villi and crypt of rat small intestine. Histochemistry and Cytochemistry, 15, 713-721.
39. OMURA, T. and SATO, R., 1964, The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. Journal of Biological Chemistry, 239, 2370-2378.
40. PETERS, W. H. and ROELOFS, H. M., 1992, Biochemical characterization of resistance to mitoxantrone and adriamycin in Caco-2 human colon adenocarcinoma cells: a possible role for glutathione S-transferases. Cancer Research, 52, 1886-1890.
41. PINKUS, L. M., 1981, Separation and use of enterocytes. In Methods in Enzymology, vol. 77, edited by W. B. Jakoby (New York: Academic), pp. 154-162.
42. PORTEOUS, J. W., FURNEAUX, H. M. and PEARSON, C. K., 1979, Poly (adenosine diphosphate ribose) synthetase activity in nuclei of dividing and of non dividing but differentiating intestinal epithelial cells. Biochemical Journal 180, 455-461.
43. QUATTROCHI, L. C., OKINO, S. T., PENDURTHI, U. R. and TUKEY, R. H., 1985, Cloning and isolation of human cytochrome P450 cDNAs homologous to Dioxin-inducible rabbit mRNAs encoding P450 4 and P450 6. DNA, 4, 395-400.
44. ROSENBERG, D. W. and LEFF, T., 1993, Regulation of cytochrome P450 in cultured human colonic cells. Archives in Biochemistry and Biophysics, 300, 186-92.
45. ROUSSET, M., LABURTHE, M., PINTO, M., CHEVALIER, G., ROUYER, F. C., DUSSAULX, E., TRUGNAN, G., BOIGE, N., BRUN, J. L. and ZWEIBAUM, A., 1985, Enterocytic differentiation and glucose utilization in the human colon tumor cell line Caco-2: modulation by forskolin. Journal of Cell Physiology, 123, 377-85.
46. SANDHU, P., GUYO, Z., BABA, T., MARTIN, M. V., TUKEY, R. H. and GUENGERICH, F. P., 1994, Expression of modified human cytochrome P450 1A2 in Escherichia coli: stabilization, purification, spectral characterization and catalytic activities of the enzyme. Archives in Biochemistry and Biophysics, 309, 168-177.
47. SCHMIEDLEN-REN, P., BENEDICT, P., DOBBINS, W., GHOSH, M., KOLARS, J. and WATKINS, P., 1993, Cultured adult rat jejunal explants as a model for studying regulation of CYP3A. Biochemical Pharmacology, 46, 905-918.
48. SIMS, P., 1970, Studies on the metabolism of 7-methylbenz[a]anthracene and 7,12-dimethylbenz(a)anthracene and its hydroxymethyl derivatives in rat liver and adrenal homogenates. Biochemical Pharmacology, 19, 2261-2275.
49. SMITH, P. K., KROHN, R. J., HERMANSON, G. T., MALLIA, A. K., GARTNER, F. K., PROVENZANO, M. D., FUJIMOTO, E. K., GOEKE, N. M., OLSON, B. J. and KLENK, D. C., 1985, Measurement of protein using bicinchoninic acid. Anals of Biochemistry, 150, 76-85.
50. UMBENAUER, D. R., MARTIN, M. V., LLOYD, S. and GUENGERICH, F. P., 1987, Cloning and sequence determination of a complementary DNA related to human liver microsomal cytochrome P450 S-Mephenytoin 4-Hydroxylase. Biochemistry, 26, 1094-1099.
51. WAXMAN, D. J., ATTISANO, C., GUENGERICH, F. P., and LAPENSON, D., 1988, Human liver microsomal steroid metabolism: identification of the major microsomal steroid hormone 6-hydroxylase cytochrome P-450 enzyme. Archives of Biochemistry and Biophysics, 263, 424-436.
52. YANG, S. K. and DOWER, W. V., 1975, Metabolic pathways of 7,12-dimethylbenz[a]anthracene in hepatic microsomes. Proceedings of the National Academy of Sciences, USA, 72, 2601-2605.
53. ZWEIBAUM, A., HAURI, H. P., STERCHI, E., CHANTRET, I., HAFFEN, K., BAMAT, J. and SORDAT, B., 1984, Immunohistological evidence, obtained with monoclonal antibodies, of small intestinal brush border hydrolases in human colon cancers and foetal colons. International Journal of Cancer, 34, 591-598.
54. ZWEIBAUM, A., TRIADOU, N., KEDINGER, M., AUGERON, C., ROBINE, L. S., PINTO, M., ROUSSET, M. and HAFFEN, K., 1983, Sucrase-isomaltase: a marker of foetal and malignant epithelial cells of the human colon. International Journal of Cancer, 32, 407-12.